The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
IDH mutation status impact on in vivo hypoxia biomarkers expression: New insights from a clinical, nuclear imaging, and immunohistochemical study in 34 patients with glioma.
P. Metellus
No relevant relationships to disclose
C. Colin
No relevant relationships to disclose
D. Taieb
No relevant relationships to disclose
E. Guedj
No relevant relationships to disclose
I. Nanni-Metellus
No relevant relationships to disclose
B. Coulibaly
No relevant relationships to disclose
C. Colavolpe
No relevant relationships to disclose
S. Fuentes
No relevant relationships to disclose
H. Dufour
No relevant relationships to disclose
M. Barrie
No relevant relationships to disclose
O. L. Chinot
No relevant relationships to disclose
L. Ouafik
No relevant relationships to disclose
D. Figarella-Branger
No relevant relationships to disclose